Oncternal Therapeutics Announces Presentation of Interim Phase 1 Clinical Trial Data for TK216 in Patients with Relapsed/Refractory Ewing Sarcoma at ESMO Virtual Congress 2020
– Complete responses reported for two patients with relapsed/refractory Ewing sarcoma treated at the recommended…
Studio4Motion Automates Content Marketing SEO Services